AILIS is a pioneering technology that detect symptoms of breast cancer and estimate the risk of developing the illness.
AILIS Breast Cancer Prediction Technology has raised $185K in total funding. The most recent round was Grant. The last funding was announced in December 2021.
AILIS Breast Cancer Prediction Technology's investors include National Center for Research & Development, Polish Agency for Enterprise Development, Business Angel, Business Angel.
AILIS Breast Cancer Prediction Technology is headquartered in Kraków, Poland.
AILIS is a pioneering technology that detect symptoms of breast cancer and estimate the risk of developing the illness.
AILIS Breast Cancer Prediction Technology is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AILIS Breast Cancer Prediction Technology — Funding & Investors." VCBacked, December 20, 2021, https://www.vcbacked.co/company/ailis-breast-cancer-prediction-technology. Accessed September 30, 2026.
VCBacked. (2021). AILIS Breast Cancer Prediction Technology — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/ailis-breast-cancer-prediction-technology
{{cite web |title=AILIS Breast Cancer Prediction Technology — Funding & Investors |url=https://www.vcbacked.co/company/ailis-breast-cancer-prediction-technology |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated